We do see a will and an intent from stakeholders, from government to physician groups, for the UK to be a global leader in life sciences.…
In Conversation
"Hong Kong has a lot of good technology and research but one of our main challenges is that Hong Kong-based companies lack the critical mass required…
"Global pharmaceutical companies are now paying a lot of attention on how they are doing business in Cyprus, looking for strong, reliable and quality-focused service providers"
"We believe that by providing useful clinical decision support tools (linked to our scanning devices) to expert clinicians, we can increase their efficiency by enabling them…
"Recently, against all odds, amid the Brexit turmoil, we were awarded a EUR 4m single company grant by Horizon2020. This was instrumental in taking a decision…
" Our main responsibility is to provide high-level quality business services which support and facilitate market entry strategies which ensure that British companies entering Turkey are…
"We are looking to attract new suppliers, placing emphasis on the high quality of the services we can provide. Indeed, we are inspected and audited very…
"It is Gilead’s mission to develop innovative treatments in areas of high unmet need. Nobody comes to work in a pharma company wanting to develop a…
What makes managing our joint affiliate work from an Amgen perspective is the cross-functional teamwork and the fact that the same portfolio is represented in both…
"At Roche Diagnostics, we have a product development process, and this process always starts with customer engagement. Our motto is to incorporate customer insights into our…
"I like to live by the motto that you cannot understand someone until you “have walked a mile in their shoes”. This helps to achieve a…
"The country is very competitive in the field of neurosciences, but we need urgently more incoming funds, better facilities, equipment, and researchers to develop a science…
